Cibc World Markets Corp Madrigal Pharmaceuticals, Inc. Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 1,681 shares of MDGL stock, worth $591,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,681Holding current value
$591,224% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
319Shares Held
22.5MCall Options Held
662KPut Options Held
686K-
Janus Henderson Group PLC London, X02.48MShares$872 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$718 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$714 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$701 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$694 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.02B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...